Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin38.7%+1.8pp36.9%+0.1pp36.8%-0.9pp37.7%+1.0pp36.7%+0.2pp
Operating margin14.3%+1.2pp13.1%+0.9pp12.2%-1.0pp13.2%+0.5pp12.7%+3.8pp
Net margin4%+1.6pp2.4%+2.2pp0.2%+0.1pp0.1%+0.6pp-0.5%+3.7pp
Free cash flow margin7.9%-1.0pp8.9%-0.1pp9%-0.9pp9.9%+1.0pp8.9%+0.2pp
Returns
Return on assets3.5%+1.5pp2%+1.8pp0.2%+0.1pp0.1%+0.5pp-0.4%+3.0pp
Return on invested capital20.1%+4.4pp15.7%+2.3pp13.4%+3.3pp10.1%+0.7pp9.4%-1.2pp
Efficiency
Asset turnover0.9×0.0×0.8×0.0×0.8×0.0×0.8×0.0×0.8×0.0×
Inventory turnover-0.1×3.1×+0.1×3.1×+0.1×-0.1×3.1×+0.1×
Liquidity
Current ratio2.5×+0.3×2.2×0.0×2.1×+0.7×1.4×0.0×1.4×0.0×
Quick ratio1.6×+0.1×1.5×+0.1×1.4×+0.5×0.9×0.0×0.8×0.0×
Cash ratio0.3×0.0×0.3×+0.1×0.2×+0.2×0.1×0.0×0.1×0.0×
Leverage
Debt-to-assets0.7×0.0×0.7×0.0×0.7×+0.1×0.6×0.0×0.6×-0.1×
Per Share
Book value per share-$0.14+36.7%-$0.22+35.3%-$0.34+3.1%-$0.35+14.4%-$0.41-14.9%
Valuation
Market capitalization$3.97B+0.1%$3.96B+26.0%$3.14B+23.4%$2.55B-3.0%$2.63B+7.0%
Enterprise value$6.34B-0.5%$6.37B+15.4%$5.52B+18.5%$4.65B-2.1%$4.75B-1.7%
Price / earnings32.5×-22.5×55×-478×532.9×-222×755×
Price / sales1.3×0.0×1.3×+0.2×1.1×+0.2×0.9×0.0×0.9×0.0×
EV / sales2.1×0.0×2.1×+0.2×1.9×+0.2×1.6×0.0×1.7×-0.1×
Free cash flow yield6.1%-0.7pp6.8%-1.6pp8.4%-2.7pp11.1%+1.5pp9.6%-0.4pp
Earnings yield3.1%+1.3pp1.8%+1.6pp0.2%+0.1pp0.1%+0.6pp-0.5%+4.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Amneal Pharmaceuticals, Inc.'s profit margins?
Amneal Pharmaceuticals, Inc. (AMRX) runs a 38.7% gross margin and a 14.3% operating margin, with a 4.0% net margin.
Where do Amneal Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Amneal Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.